Le Lézard
Classified in: Health
Subject: SVY

United States Interventional Cardiology Product Portfolio 2018


DUBLIN, July 18, 2018 /PRNewswire/ --

The "US Product Portfolio for Interventional Cardiology 2018 - MedFolio" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

There are many different types of complementary devices used during interventional cardiology procedures. These devices include coronary stents, coronary balloon catheters, balloon-inflation devices, coronary catheters and guidewires, coronary embolic protection devices, coronary atherectomy devices, coronary thrombectomy devices, coronary chronic total occlusion devices, coronary introducer sheaths, coronary vascular closure devices, diagnostic coronary catheter and guidewire, intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.

Key Topics Covered:

EXECUTIVE SUMMARY
U.S. Interventional Cardiology Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History

1. RESEARCH METHODOLOGY

2. DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS AND DIAGNOSTICS
2.2.1 General Diagnostics
2.2.2 Coronary Artery Disease (CAD)
2.2.3 Myocardial Infarction (MI)
2.2.4 Angina Pectoris
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Statistics

3. CORONARY ATHERECTOMY DEVICE MARKET
3.1 INTRODUCTION
3.1.1 Atherectomy
3.1.2 Device Technologies
3.1.2.1 Mechanical Atherectomy
3.1.2.2 Laser Atherectomy
3.1.2.3 Directional Coronary Atherectomy (DCA)
3.2 MARKET OVERVIEW
3.3 MARKET ANALYSIS AND FORECAST
3.3.1 Total Coronary Atherectomy Device Market
3.3.2 Mechanical Atherectomy Device Market
3.3.3 Laser Atherectomy Device Market
3.4 DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX I: COMPANY PRESS RELEASES

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/research/wn9cm7/united_states?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 07:35
Cybin Inc. (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based treatment options, today announced...

at 07:35
Accuray Incorporated announced today that the company is showcasing advances in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife® and Radixact® platforms provide medical care...

at 07:30
Jushi Holdings Inc. ("Jushi" or the "Company") , a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the first quarter ended March 31, 2024, after the market closes on Thursday, May...

at 07:30
Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto,...

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has received notice of intent...

at 07:25
Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has secured funding from the Bill & Melinda Gates Foundation ("the Gates Foundation" or "the...



News published on and distributed by: